Vapogenix Secures $8.2 Million in Series C Funding to Advance Innovative Therapy for Wound Pain HOUSTON, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Vapogenix, Inc., a clinical-stage company developing a topical, non-opioid medicine for localized pain, has raised $8.2 million to advance the development...